USPTO Examiner REDDEN KAREN M - Art Unit 1661

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18831858Delosperma plant named 'Electric Slide'October 2025January 2026Allow300NoNo
18831805Miniature rose plant named 'Poulpar137'September 2025February 2026Allow500NoNo
18831806Miniature Rose Plant Named 'Poulty038'September 2025February 2026Allow500NoNo
19287954Caladium Plant Named 'UF-15-131'August 2025October 2025Allow300NoNo
19288552Calathea Plant Named 'HGV23'August 2025October 2025Allow300NoNo
19286026Kalanchoe Plant Named 'KLEKB24053'July 2025September 2025Allow100NoNo
19278321BIDENS PLANT NAMED 'KLEBF24674'July 2025October 2025Allow300NoNo
19278561RASPBERRY PLANT NAMED 'DRISRASPTWENTYFIVE'July 2025October 2025Allow300NoNo
19276867Dianthus Plant Named 'KLEDA26818'July 2025October 2025Allow300NoNo
19219620GRAPEVINE PLANT NAMED 'NAVSEL 70'May 2025October 2025Allow500NoNo
19217038Floribunda Rose Plant Named 'KORfloci114'May 2025August 2025Allow300NoNo
19195758Hop Plant Named 'NZH-3077'May 2025October 2025Allow610NoNo
19195238Gasteraloe plant named 'D Overflow'April 2025June 2025Allow200YesNo
19191341Euphorbia Plant Named 'WALEULITR'April 2025June 2025Allow200NoNo
19189636Pelargonium Plant Named 'KLEPZ24878'April 2025December 2025Allow810NoNo
19188462Pelargonium Plant Named 'KLEPZ24856'April 2025November 2025Allow710NoNo
19179441Pelargonium Plant Named 'KLEPZ24880'April 2025August 2025Allow400NoNo
19179527Hydrangea plant named 'WNHYDFBLAMH'April 2025August 2025Allow400NoNo
18831548Grapevine Named 'SV34-161-275'April 2025August 2025Allow400NoNo
18831549Grapevine Named 'SV35-206-150'April 2025August 2025Allow400NoNo
19177619Sedum Plant Named 'PPC093'April 2025August 2025Allow400NoNo
19171330PHALAENOPSIS PLANT NAMED 'KEYNOTE'April 2025August 2025Allow400NoNo
19096409PHALAENOPSIS PLANT NAMED 'MI02673'March 2025May 2025Allow200NoNo
19093595Adiantum plant named 'Tassels'March 2025October 2025Allow710NoNo
19089983Dianthus Plant Named 'KLEDG27706'March 2025June 2025Allow300NoNo
19089479Dianthus Plant Named 'KLEDG24627'March 2025June 2025Allow300NoNo
19085360Taxodium plant named 'TAMTF'March 2025June 2025Allow300NoNo
19071224PORTULACA PLANT NAMED 'LAZZPOR5316'March 2025June 2025Allow300NoNo
19067885PETUNIA PLANT NAMED 'KEIPEBBCMAM'March 2025June 2025Allow400NoNo
19063460BLUEBERRY PLANT NAMED 'FCE18-015'February 2025January 2026Allow1110YesNo
18831491Hoya Plant Named 'G4Y0002'February 2025February 2026Allow1200YesNo
19053502GRAPEVINE PLANT NAMED 'BLOMG06'February 2025August 2025Allow610NoNo
19053014BLACKBERRY PLANT NAMED 'DRISBLACKTHIRTYSIX'February 2025July 2025Allow510NoNo
19048919Geranium Plant Named 'MVNG1901'February 2025May 2025Allow300NoNo
19048908Thuja Plant Named 'GK01'February 2025September 2025Allow710NoNo
19048875Sanguisorba Plant Named 'Black Dream Select'February 2025April 2025Allow200NoNo
18831477Crassula Plant Named 'OVWOODS06'February 2025June 2025Allow400NoNo
19042489GRAPEVINE PLANT NAMED ‘SUGRA66’January 2025July 2025Allow510NoNo
19042944GRAPEVINE PLANT NAMED ‘SUGRA68’January 2025July 2025Allow510YesNo
19041926DRACAENA PLANT NAMED 'LULU'January 2025August 2025Allow610NoNo
18831467Agastache plant named 'PINKY PIE'January 2025April 2025Allow200NoNo
19038066Cornus plant named 'Rutstar'January 2025August 2025Allow710NoNo
19038364PINEAPPLE PLANT NAMED 'FR20966'January 2025November 2025Allow910NoNo
18831411CHRYSANTHEMUM PLANT NAMED 'CIFZ0114'January 2025August 2025Allow710NoNo
19030050HYDRANGEA PLANT NAMED 'HYLV19557'January 2025June 2025Allow500NoNo
19026197Impatiens plant named 'DIMPSLPRRD'January 2025April 2025Allow300NoNo
19022269Hibiscus plant named 'ALTbirdy'January 2025July 2025Allow600NoNo
19022320Hibiscus plant named 'ALTpinky'January 2025April 2025Allow300YesNo
19022344Hibiscus plant named 'ALTodired'January 2025April 2025Allow300NoNo
19022369Hibiscus plant named 'ALTbigbird'January 2025July 2025Allow600YesNo
19019856GRAPEVINE PLANT NAMED 'BLOMG03'January 2025April 2025Allow300NoNo
19006027CHRYSANTHEMUM PLANT NAMED 'G24MAG04YE'December 2024April 2025Allow300NoNo
19006038CHRYSANTHEMUM PLANT NAMED 'G24MAG11OR'December 2024May 2025Allow400NoNo
19004951Hydrangea Plant Named '3792resgea'December 2024April 2025Allow300NoNo
19004681Syringa Plant Named 'G13110'December 2024April 2025Allow300NoNo
19004282ZANTEDESCHIA PLANT NAMED 'DO21PW104'December 2024March 2025Allow300NoNo
18991825Epipremnum plant named 'Cla20241218'December 2024June 2025Allow510NoNo
19000646Sansevieria plant named 'Hansoti56'December 2024March 2025Allow300NoNo
19000642Sansevieria plant named 'Hansoti55'December 2024March 2025Allow300NoNo
18989465Miniature Rose Plant Named 'KORpot131'December 2024March 2025Allow300NoNo
18831377Hosta plant named 'Moment to Treasure'December 2024March 2025Allow300NoNo
18985281Agave plant named 'Goldrush'December 2024May 2025Allow510NoNo
18977904BLUEBERRY PLANT NAMED 'FL16-754'December 2024March 2025Allow300YesNo
18976311LANTANA PLANT NAMED 'DOLANHAVFUMO'December 2024August 2025Allow910NoNo
18976316LANTANA PLANT NAMED 'DOLANHAVHARMO'December 2024March 2025Allow300NoNo
18967915Helianthus plant named 'DHELSOSKBB'December 2024March 2025Allow300NoNo
18968358Epipremnum Plant Named 'UF-Ea-0314'December 2024March 2025Allow410NoNo
18956252BIDENS PLANT NAMED 'DPWBIDCAPR'November 2024February 2025Allow300NoNo
18955815HELLEBORUS PLANT NAMED 'BORUSMURA38'November 2024February 2025Allow300NoNo
18947816VIBURNUM PLANT NAMED 'SMNVCST'November 2024January 2025Allow300NoNo
18946908PHALAENOPSIS PLANT NAMED 'MI02969'November 2024February 2025Allow300NoNo
18944163MANDARIN PLANT NAMED 'Mikanken4'November 2024July 2025Allow810NoNo
18938360Heliopsis plant named 'VENSGC'November 2024May 2025Allow610NoNo
18935725Rhododendron plant named 'ROBLEZN'November 2024February 2025Allow300NoNo
18933357Hibiscus plant named 'G21086'October 2024January 2025Allow200NoNo
18931751HYPERICUM PLANT NAMED 'ALLHYBELL'October 2024January 2025Allow300NoNo
18931397Cornus Plant Named 'Zelroc3423'October 2024January 2025Allow300NoNo
18931660BLACKBERRY PLANT NAMED 'DRISBLACKTHIRTYFIVE'October 2024January 2025Allow300NoNo
18929687Miniature Rose Plant Named 'KORpot135'October 2024January 2025Allow300NoNo
18925753Dianthus plant named 'G19159'October 2024January 2025Allow300NoNo
18924897STRAWBERRY PLANT NAMED 'DRISSTRAWONEHUNDREDNINE'October 2024January 2025Allow300NoNo
18831287Colocasia Plant Named 'FLOCOCLEO'October 2024January 2025Allow300NoNo
18917732AGERATUM PLANT NAMED 'AGERBOYUMA'October 2024January 2025Allow300NoNo
18917877GERANIUM PLANT NAMED 'TOSPL200522'October 2024January 2025Allow300NoNo
18915650TECOMA PLANT NAMED 'TEC60109107'October 2024October 2025Allow1220NoNo
18914243AGASTACHE PLANT NAMED 'BALSUMLEAC'October 2024May 2025Allow700NoNo
18914143COREOPSIS PLANT NAMED 'BALUPTOLD'October 2024May 2025Allow700NoNo
18912730Buddleja Plant Named 'Botex 012'October 2024January 2025Allow300NoNo
18831281Monstera plant named `MKR-MTCM1'October 2024December 2024Allow200NoNo
18911551Alpinia plant named 'Crispy'October 2024April 2025Allow610NoNo
18912517Agapanthus Plant Named 'DwAgHybPi’October 2024January 2025Allow300YesNo
18910908APPLE TREE NAMED 'FARMER NO.4'October 2024August 2025Allow1010YesNo
18831232SEEDLESS GRAPEVINE PLANT NAMED 'ARD47'October 2024January 2025Allow300NoNo
18905111SCAEVOLA PLANT NAMED 'DSCAPW1335'October 2024October 2025Allow1210NoNo
18896970Dahlia plant named 'DDAHCHPCHP'September 2024December 2024Allow300NoNo
18896794CATHARANTHUS PLANT NAMED 'SUNCATH 842'September 2024May 2025Allow700NoNo
18896786CATHARANTHUS PLANT NAMED 'SUNCATH 803'September 2024May 2025Allow800NoNo
18831220Vanda Plant Named 'SPCDW2303'September 2024December 2024Allow300NoNo
18889489Chamelaucium plant named 'Grand Adi'September 2024April 2025Allow610NoNo
18884644BLUEBERRY PLANT NAMED ‘CBG-23-02’September 2024May 2025Allow810NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner REDDEN, KAREN M.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
0
(0.0%)
Examiner Reversed
2
(100.0%)
Reversal Percentile
91.4%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
5
Allowed After Appeal Filing
2
(40.0%)
Not Allowed After Appeal Filing
3
(60.0%)
Filing Benefit Percentile
64.9%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner REDDEN, KAREN M - Prosecution Strategy Guide

Executive Summary

Examiner REDDEN, KAREN M works in Art Unit 1661 and has examined 1,113 patent applications in our dataset. With an allowance rate of 94.0%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 13 months.

Allowance Patterns

Examiner REDDEN, KAREN M's allowance rate of 94.0% places them in the 82% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by REDDEN, KAREN M receive 0.66 office actions before reaching final disposition. This places the examiner in the 4% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by REDDEN, KAREN M is 13 months. This places the examiner in the 99% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -23.6% benefit to allowance rate for applications examined by REDDEN, KAREN M. This interview benefit is in the 1% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 15.7% of applications are subsequently allowed. This success rate is in the 12% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 48.5% of cases where such amendments are filed. This entry rate is in the 73% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 14% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 65.8% are granted (fully or in part). This grant rate is in the 71% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.1% of allowed cases (in the 50% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

    Relevant MPEP Sections for Prosecution Strategy

    • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
    • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
    • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
    • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
    • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
    • MPEP § 1214.07: Reopening prosecution after appeal

    Important Disclaimer

    Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

    No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

    Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

    Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.